Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Curnow

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Thrombosis Research|September 16, 2021
Two Weeks of Low Molecular Weight Heparin for Isolated Symptomatic Distal Vein Thrombosis (TWISTER study)Eileen Merriman, Sanjeev Chunilal, Tim Brighton, et al.
Pathology|July 18, 2024
Indeterminate measurable residual disease by multiparameter flow cytometry is associated with an intermediate risk of clinical relapse in adult patients with acute leukaemiaMaxine Revoltar, Riana van der Linde, Deborah Cromer, et al.
Internal Medicine Journal|October 19, 2016
Formalising multidisciplinary peer review: developing a haematological malignancy-specific electronic proforma and standard operating procedure to facilitate procedural efficiency and evidence-based clinical practiceJudith Trotman, Jimmy Trinh, Yiu Lam Kwan, et al.
Research and Practice in Thrombosis and Haemostasis|October 3, 2022
Treatment of immune thrombocytopenia in Australian adults: A multicenter retrospective observational studyAdam Rosenberg, Catelyn Cashion, Fariya Ali, et al.
Research and Practice in Thrombosis and Haemostasis|December 19, 2022
Immune thrombocytopenia and COVID-19 vaccination: Outcomes and comparisons to prepandemic patientsPhilip Young-Ill Choi, Danny Hsu, Huyen Anh Tran, et al.
Internal Medicine Journal|March 18, 2024
Pulmonary embolism response teams. A description of the first 36-month Australian experienceBapti Roy, Jin-Gun Cho, Luke Baker, et al.
Blood Advances|September 3, 2024
Ibrutinib plus rituximab and mini-CHOP in older patients with newly diagnosed DLBCL: a phase 2 ALLG studyEmma Verner, Amanda Johnston, Nalini Pati, et al.
Research and Practice in Thrombosis and Haemostasis|August 21, 2023
Direct oral anticoagulants or vitamin K antagonists in emergencies: comparison of management in an observational studyRoss I Baker, Grace Gilmore, Vivien Chen, et al.
BMJ Open|January 18, 2024
Efficacy and safety of avatrombopag in combination with immunosuppressive therapy in treatment-naïve and relapsed/refractory severe aplastic anaemia: protocol for the DIAAMOND-Ava-FIRST and DIAAMOND-Ava-NEXT Bayesian Optimal Phase II trialsZoe McQuilten, Stephane Heritier, Lucy Fox, et al.
Blood Research|January 12, 2023
Validating lactate dehydrogenase (LDH) as a component of the PLASMIC predictive tool (PLASMIC-LDH)Christopher Chin Keong Liam, Jim Yu-Hsiang Tiao, Yee Yee Yap, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Thrombosis Research|September 16, 2021
Two Weeks of Low Molecular Weight Heparin for Isolated Symptomatic Distal Vein Thrombosis (TWISTER study)Eileen Merriman, Sanjeev Chunilal, Tim Brighton, et al.
Pathology|July 18, 2024
Indeterminate measurable residual disease by multiparameter flow cytometry is associated with an intermediate risk of clinical relapse in adult patients with acute leukaemiaMaxine Revoltar, Riana van der Linde, Deborah Cromer, et al.
Internal Medicine Journal|October 19, 2016
Formalising multidisciplinary peer review: developing a haematological malignancy-specific electronic proforma and standard operating procedure to facilitate procedural efficiency and evidence-based clinical practiceJudith Trotman, Jimmy Trinh, Yiu Lam Kwan, et al.
Research and Practice in Thrombosis and Haemostasis|October 3, 2022
Treatment of immune thrombocytopenia in Australian adults: A multicenter retrospective observational studyAdam Rosenberg, Catelyn Cashion, Fariya Ali, et al.
Research and Practice in Thrombosis and Haemostasis|December 19, 2022
Immune thrombocytopenia and COVID-19 vaccination: Outcomes and comparisons to prepandemic patientsPhilip Young-Ill Choi, Danny Hsu, Huyen Anh Tran, et al.
Internal Medicine Journal|March 18, 2024
Pulmonary embolism response teams. A description of the first 36-month Australian experienceBapti Roy, Jin-Gun Cho, Luke Baker, et al.
Blood Advances|September 3, 2024
Ibrutinib plus rituximab and mini-CHOP in older patients with newly diagnosed DLBCL: a phase 2 ALLG studyEmma Verner, Amanda Johnston, Nalini Pati, et al.
Research and Practice in Thrombosis and Haemostasis|August 21, 2023
Direct oral anticoagulants or vitamin K antagonists in emergencies: comparison of management in an observational studyRoss I Baker, Grace Gilmore, Vivien Chen, et al.
BMJ Open|January 18, 2024
Efficacy and safety of avatrombopag in combination with immunosuppressive therapy in treatment-naïve and relapsed/refractory severe aplastic anaemia: protocol for the DIAAMOND-Ava-FIRST and DIAAMOND-Ava-NEXT Bayesian Optimal Phase II trialsZoe McQuilten, Stephane Heritier, Lucy Fox, et al.
Blood Research|January 12, 2023
Validating lactate dehydrogenase (LDH) as a component of the PLASMIC predictive tool (PLASMIC-LDH)Christopher Chin Keong Liam, Jim Yu-Hsiang Tiao, Yee Yee Yap, et al.
Pageof 6